ctcbio Inc

We are seeking a healthy future through continuous research and innovation. **For medical and healthcare:** We have developed CDFR0812-15/50mg, a combination drug for the treatment of premature ejaculation and erectile dysfunction, which has been approved by the KFDA. This is the worlds first combination therapy, offering a new treatment option. As a leader in Orally Disintegrating Film (ODF) manufacturing technology, we have developed innovative formulation technologies that enable convenient administration and rapid efficacy of drugs. This technology provides patients with a better treatment experience and strengthens ctcbios competitiveness in the global market. Our Microbiome Research Institute has developed advanced probiotics...

Pharmaceutical,medical,healthcare,animal health,health functional food,probiotics,odf,digestive health,animal feed,antibiotics,analgesic,antipyretic,bacteriophage,animal feed additives,β-mannanase,ctczyme,nutraceuticals,biotechnology,antibiotic alternatives,and odm

Ctcbio inc operates in the Pharmaceutical manufacturing industry.

Ctcbio inc's revenue is 101m - 500m

Ctcbio inc has 11 - 50 employees.